26/03/2015 22:02:32 Free Membership Login

Bristol Myers Sqibb News (NYSE:BMY)

03/24/20159:08AMSEEKMerck's Keytruda tops Bristol-Myers' Yervoy in melanoma trial
http://seekingalpha.com/news/2387966-mercks-keytruda-tops-bristol-myers-yervoy-in-melanoma-trial?source=partner_advfn More...>>
03/24/20158:52AMSEEKBristol-Myers Squibb's Opdivo Breezes Through FDA; Multiple Catalysts To Come
http://seekingalpha.com/article/3023896-bristol-myers-squibbs-opdivo-breezes-through-fda-multiple-catalysts-to-come?source=partner_advfn More...>>
03/24/20158:40AMSEEKBristol-Myers Squibb nabs exclusive license for autoimmune diseases discovery research program from Novo Nordisk
http://seekingalpha.com/news/2387826-bristol-myers-squibb-nabs-exclusive-license-for-autoimmune-diseases-discovery-research-program-from-novo-nordisk?source=partner_advfn More...>>
03/24/20158:00AMBWBristol-Myers Squibb Acquires Exclusive License from Novo Nordisk for a Discovery Research Program Focused on Autoimmune Dise...
Bristol-Myers Squibb Company (NYSE:BMY) today announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases. Terms of... More...>>
03/23/20158:19PMSEEKBristol-Myers Is Playing Chess, Gilead And AbbVie Are Playing Checkers
http://seekingalpha.com/article/3022746-bristol-myers-is-playing-chess-gilead-and-abbvie-are-playing-checkers?source=partner_advfn More...>>
03/23/20157:02AMTMF3 Big Pharma Stocks Wall Street Is Wrong About
http://www.fool.com/investing/general/2015/03/23/3-big-pharma-stocks-wall-street-is-wrong-about.aspx?source=eptadnlnk0000002 More...>>
03/22/20155:46AMSEEKWeek In Review: China's Innovent And Lilly Form $456 Million Cancer Biologics Alliance
http://seekingalpha.com/article/3018916-week-in-review-chinas-innovent-and-lilly-form-456-million-cancer-biologics-alliance?source=partner_advfn More...>>
03/18/20157:59AMTMFWhy I'm Not Giving Up on This Tiny Biotech Stock (Yet)
http://www.fool.com/investing/general/2015/03/18/why-im-not-giving-up-on-this-tiny-biotech-stock-ye.aspx?source=eptadnlnk0000002 More...>>
03/17/201511:07AMTMFBristol-Myers Squibb Co. Is Back in the Hepatitis C Race
http://www.fool.com/investing/general/2015/03/17/bristol-myers-squibb-co-is-back-in-the-hepatitis-c.aspx?source=eptadnlnk0000002 More...>>
03/16/201510:45PMSEEKBMY's Daclatasvir Is Good, But Gilead's GS-5816 Is Better
http://seekingalpha.com/article/3005556-bmys-daclatasvir-is-good-but-gileads-gsminus-5816-is-better?source=partner_advfn More...>>
03/16/20159:10AMSEEKBristol Myers Squibb's Strategic Acquisitions & Agreements: Long Term Growth In Sight?
http://seekingalpha.com/article/3003426-bristol-myers-squibbs-strategic-acquisitions-and-agreements-long-term-growth-in-sight?source=partner_advfn More...>>
03/12/20153:00PMBWBristol-Myers Squibb Announces Acceptance of New Drug Application for Investigational Daclatasvir for FDA Review for the Trea...
The NDA contains data to support approval for daclatasvir in combination with sofosbuvir; would be the first 12-week regimen specifically for the treatment of hepatitis C genotype 3 The application is based on a Phase III clinical trial which tested a 12-week, ribavirin-free regimen and resulted in sustained virologic... More...>>
03/12/20157:57AMTMFBetter Dividend Stock: Pfizer Inc. vs. Bristol-Myers Squibb Co.
http://www.fool.com/investing/general/2015/03/12/better-dividend-stock-pfizer-inc-vs-bristol-myers.aspx?source=eptadnlnk0000002 More...>>
03/10/20156:49PMSEEKComparing America's Next 3 Major Drug Manufacturers
http://seekingalpha.com/article/2990126-comparing-americas-next-3-major-drug-manufacturers?source=partner_advfn More...>>
03/09/20151:30PMDJNCorrection to Bristol-Myers Squibb CEO Pay Article on Friday
Dr. Giovanni Caforio, who will become Bristol-Myers Squibb Co.'s chief executive officer on May 5, is currently the company's chief operating officer. Retiring CEO Lamberto Andreotti will become executive chairman through his retirement on Aug. 3, when he will become non-executive chairman. "Bristol-Myers Squibb Sets Pay... More...>>
03/06/20155:48PMDJNBristol-Myers Squibb Sets Pay for Incoming, Retiring CEOs
By Maria Armental Bristol-Myers Squibb Co.'s (BMY) incoming executive director will be paid $1.4 million, in addition to a performance bonus, according to a regulatory filing. Dr. Giovanni Caforio, the current chief financial officer who will assume the new role on May 5, is eligible for up to $2.1 million in bonus pay... More...>>
03/05/20157:45AMSEEKMarket Is Looking For Positive News - Cramer's Mad Money (3/4/15)
http://seekingalpha.com/article/2975596-market-is-looking-for-positive-news-cramers-mad-money-3-4-15?source=partner_advfn More...>>
03/05/20156:32AMSEEKWall Street Breakfast: Signs Of A Top?
http://seekingalpha.com/article/2975046-wall-street-breakfast-signs-of-a-top?source=partner_advfn More...>>
03/05/201512:22AMSEEKBristol-Myers' Label Expansion Is Significant, But The Stock Is Not Worth Buying
http://seekingalpha.com/article/2974706-bristol-myers-label-expansion-is-significant-but-the-stock-is-not-worth-buying?source=partner_advfn More...>>
03/04/20154:13PMBWFDA Approves Opdivo (nivolumab) for the Treatment of Patients with Previously Treated Metastatic Squamous Non-Small Cell Lung...
Opdivo is the first and only immuno-oncology therapy proven to extend survival in patients treated with one prior therapy CheckMate -017 achieved the benchmark goal of improving overall survival in previously treated squamous non-small cell lung cancer (NSCLC) Bristol-Myers Squibb Company (NYSE:BMY) today announced that... More...>>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse bmy150326 22:02